Syon Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
5,112
+326
+7% +$90.2K 0.05% 307
2026
Q1
$1.41M Buy
4,786
+173
+4% +$51.4K 0.07% 214
2025
Q4
$1.26M Buy
4,613
+362
+9% +$98.4K 0.06% 234
2025
Q3
$1.15M Buy
4,251
+273
+7% +$74.3K 0.06% 229
2025
Q2
$1.1M Buy
3,978
+180
+5% +$49K 0.07% 191
2025
Q1
$1.01M Buy
3,798
+543
+17% +$134K 0.08% 185
2024
Q4
$756K Buy
3,255
+954
+41% +$219K 0.07% 198
2024
Q3
$508K Sell
2,301
-635
-22% -$131K 0.04% 274
2024
Q2
$577K Sell
2,936
-187
-6% -$38.6K 0.05% 235
2024
Q1
$672K Buy
3,123
+1,137
+57% +$239K 0.06% 218
2023
Q4
$418K Buy
1,986
+158
+9% +$33.7K 0.04% 282
2023
Q3
$366K Buy
+1,828
New +$363K 0.05% 239

Other funds holding CME

Syon Capital's CME Position: Q2 2026 in Review

Syon Capital increased its CME Group (CME) stake by 6.8% in Q2 2026, buying an estimated $90.2K and bringing the position to 5,112 shares worth $1.13M. The position accounts for 0.05% of the portfolio, ranked #307.

Syon Capital first reported a position in CME in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.41M in Q1 2026. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Syon Capital held 5,112 shares of CME Group worth $1.13M as of Q2 2026.
  • Syon Capital bought 326 CME Group shares in Q2 2026, an estimated $90.2K.
  • CME Group made up 0.05% of Syon Capital's portfolio in Q2 2026, its #307 holding.
  • Syon Capital first reported a position in CME Group in Q3 2023 and has held it in 12 quarters since.
  • Syon Capital's CME Group position peaked at $1.41M in Q1 2026.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.